Comparison of Wound Healing Complications After Anterior Total Hip Arthroplasty Using Povidone-iodine or Chlorhexidine as Antiseptic Wash

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this research trial is to evaluate the effect of two types of washing solutions on wound healing after total hip replacement surgery. Washing solutions are used routinely during total hip replacements to clean the wound after the components have been placed and the wound is about to be closed with sutures. It is currently not known which washing solution may be better for wound healing and whether a certain solution decreases the risk of wound healing complications after total hip replacement. Therefore, this research trial is being conducted. Study participants will be randomized into one of two groups: washing the surgical wound with povidone-iodine solution (Surgiphor, Becton Dickinson, Franklin Lakes, NJ) or chlorhexidine solution (Irrisept, Irrimax Corporation, Lawrenceville, GA). All patients will undergo standard of care total hip replacements without any other change in surgery. The best type of solution that cleans the wound and potentially leads to better wound healing is unknown. This study will evaluate whether there is difference in surgical wound healing between the two washing solutions. The study will pay for the washing solutions. Patients will follow up for standard postoperative visits. At the 2-week and 6-week visits, pictures of the surgical incision will be taken and saved in the electronic medical record and evaluated in a standardized way for healing of the incision and the appearance of the scar. Postoperative complications and returns to the hospital or additional surgeries will be collected from the electronic medical record.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• osteoarthritis or avascular necrosis of the femoral head, failed conservative management, indicated for total hip replacement

Locations
United States
Pennsylvania
UPMC East
RECRUITING
Monroeville
UPMC Shadyside
RECRUITING
Pittsburgh
Contact Information
Primary
Frank J Plate, MD, PhD
platefj2@upmc.edu
(412) 687-3900
Backup
Dana Farrell, BS,PMP
djf52@pitt.edu
(412) 383-0955
Time Frame
Start Date: 2025-10-08
Estimated Completion Date: 2028-01-01
Participants
Target number of participants: 420
Treatments
Experimental: Chlorhexidine washing solution
Following component implantation a 3-minute chlorhexidine lavage followed by saline lavage will be performed.
Experimental: Povidone-iodine washing solution
Following component implantation a 3-minute povidone-iodine lavage followed by saline lavage will be performed.
Sponsors
Collaborators: Irrimax Corporation
Leads: F. Johannes Plate

This content was sourced from clinicaltrials.gov